Answer
Voraxaze (glucarpidase) is indicated to reduce toxic plasma methotrexate concentrations in adults and children aged 28 days and older with delayed methotrexate elimination.
Sources for this answer
- VoraxazeSERB · emc · SmPC §4.1 Therapeutic Indications · Version 1Document updated
Sources checked